We are live on
!
Find out more
SG Americas Securities Portfolio holdings
AUM
$92.9B
1-Year Est. Return
36.98%
This Fund
S&P 500
This Quarter
Est. Return
-6.3%
1 Year Est. Return
+36.98%
3 Year Est. Return
+96.33%
5 Year Est. Return
+110.18%
10 Year Est. Return
+436.29%
AUM
$30.5B
AUM Growth
+$6.11B
(+25%)
Cap. Flow
+$9.67B
Cap. Flow
% of AUM
31.72%
Top 10 Holdings %
Top 10 Hldgs %
46.6%
Holding
3,856
New
751
Increased
1,330
Reduced
1,206
Closed
418
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$507M |
| 3 |
NVIDIA
NVDA
|
+$470M |
| 4 |
Meta Platforms (Facebook)
META
|
+$404M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 2 |
Broadcom
AVGO
|
+$292M |
| 3 |
Oracle
ORCL
|
+$111M |
| 4 |
Microsoft
MSFT
|
+$109M |
| 5 |
Intuit
INTU
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.72% |
| 2 | Communication Services | 17.72% |
| 3 | Healthcare | 7.71% |
| 4 | Financials | 7.66% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
CALL
Best Buy
BBY
$18.2B
| $18K | ﹤0.01% |
22,600
-25,000
| -53% | -$2.06M |
|
3302
FibroBiologics
FBLG
$5M
| $18K | ﹤0.01% |
+1,026
| New | +$29.3K |
|
|
CLYM
3303
Climb Bio
CLYM
$719M
| $18K | ﹤0.01% |
14,811
-16,177
| -52% | -$26.2K |
|
3304
PUT
Gilead Sciences
GILD
$168B
| $17K | ﹤0.01% |
48,300
| – | – |
|
|
AKYA
3305
DELISTED
Akoya BioSciences
AKYA
| $16K | ﹤0.01% |
11,362
-963
| -8% | -$2.11K |
|
|
OGI
3306
Organigram Holdings
OGI
$140M
| $16K | ﹤0.01% |
+16,205
| New | +$21.6K |
|
|
SCHW
3307
PUT
Charles Schwab
SCHW
$185B
| $16K | ﹤0.01% |
49,000
-96,200
| -66% | -$7.55M |
|
3308
TELA Bio
TELA
$40.6M
| $16K | ﹤0.01% |
+12,769
| New | +$31.4K |
|
3309
PUT
Fastenal
FAST
$57B
| $15K | ﹤0.01% |
78,600
| – | – |
|
|
HLVX
3310
DELISTED
HilleVax
HLVX
| $15K | ﹤0.01% |
10,034
-8,111
| -45% | -$15K |
|
|
INZY
3311
DELISTED
Inozyme Pharma
INZY
| $15K | ﹤0.01% |
16,161
+227
| +1% | +$315 |
|
3312
CALL
Keysight
KEYS
$58.3B
| $15K | ﹤0.01% |
11,700
+1,700
| +17% | +$281K |
|
3313
ALX Oncology
ALXO
$265M
| $14K | ﹤0.01% |
22,277
-1,979
| -8% | -$2.38K |
|
3314
374Water
SCWO
$38.7M
| $14K | ﹤0.01% |
4,083
-595
| -13% | -$2.63K |
|
|
NOVA
3315
DELISTED
Sunnova Energy
NOVA
| $13K | ﹤0.01% |
34,494
-19,212
| -36% | -$37K |
|
3316
Ovid Therapeutics
OVID
$474M
| $13K | ﹤0.01% |
43,028
+5,392
| +14% | +$3.32K |
|
3317
Prelude Therapeutics
PRLD
$360M
| $13K | ﹤0.01% |
+17,251
| New | +$16.1K |
|
3318
Verrica Pharmaceuticals
VRCA
$92.9M
| $13K | ﹤0.01% |
2,873
+971
| +51% | +$6.28K |
|
3319
CALL
Biogen
BIIB
$30.8B
| $12K | ﹤0.01% |
18,300
-12,200
| -40% | -$1.74M |
|
3320
CALL
Hewlett Packard
HPE
$69.4B
| $12K | ﹤0.01% |
+50,000
| New | +$996K |
|
3321
Century Therapeutics
IPSC
$363M
| $12K | ﹤0.01% |
25,314
+5,931
| +31% | +$4.46K |
|
3322
MarketWise
MKTW
$56.5M
| $12K | ﹤0.01% |
1,187
+7
| +0.6% | +$84 |
|
|
MRSN
3323
DELISTED
Mersana Therapeutics
MRSN
| $12K | ﹤0.01% |
1,421
-3,071
| -68% | -$47.4K |
|
3324
Cognition Therapeutics
CGTX
$88.3M
| $10K | ﹤0.01% |
23,107
-14,001
| -38% | -$8.23K |
|
3325
Tenaya Therapeutics
TNYA
$161M
| $10K | ﹤0.01% |
17,168
-24,102
| -58% | -$23.8K |
|
Similar funds
SG Americas Securities's Q1 2025 Portfolio in Review
As of Q1 2025, SG Americas Securities held 3,856 positions worth $30.5B, up 25% from $24.4B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
SG Americas Securities deployed $9.67B of net new capital in Q1 2025, opening 751 new positions and adding to 1,330 existing holdings. Its largest new stake was Biogen: 719,793 shares worth $98.5M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 40% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $409M trimmed.
- SG Americas Securities's largest Q1 2025 buy was Biogen: 719,793 shares worth $98.5M.
- SG Americas Securities added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $1.46B increase.
- SG Americas Securities's biggest Q1 2025 reduction was Alphabet (Google) Class A, cutting an estimated $409M.
- SG Americas Securities fully exited iShares Ethereum Trust ETF in Q1 2025, selling an estimated $49.8M.
- SG Americas Securities's ten largest holdings make up 47% of its $30.5B portfolio in Q1 2025.
- SG Americas Securities opened 751 new positions and closed 418 in Q1 2025.
- SG Americas Securities's portfolio value rose 25% quarter-over-quarter to $30.5B.
Based on SG Americas Securities's 13F filing for Q1 2025, filed 15 Apr 2025.